LogicBio Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
LogicBio Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2021.
  • LogicBio Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2022 was -115 %, a 51.7% decline year-over-year.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2021 was -95 %, a 5.99% decline from 2020.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2020 was -89.6 %, a 29.4% decline from 2019.
  • LogicBio Therapeutics, Inc. annual Return On Equity for 2019 was -69.3 %, a 64.1% increase from 2018.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 -95 -5.37 -5.99% Jan 1, 2021 Dec 31, 2021
2020 -89.6 -20.4 -29.4% Jan 1, 2020 Dec 31, 2020
2019 -69.3 +124 +64.1% Jan 1, 2019 Dec 31, 2019
2018 -193 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.